Fact CheckerSign in

NCT07076732Completed

Beyond Platelet Indices, WBC-to-MPV Ratio in Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) Correlate With Short-Term Rather Than In-Hospital Outcomes

Source: ClinicalTrials.gov · Last updated 13 Mar 2026

Brief summary (registry, in English)

This study aims to evaluate the role of platelet indices and the \[White blood cell (WBC) /mean platelet volume (MPV)\] ratio in correlation with angiographic profiles of patients diagnosed with myocardial infarction with non-obstructive coronary arteries (MINOCA) to assess their predictive value for short-term clinical outcomes.

Status (registry)
Completed
Study type
Observational
Enrollment
80 (actual)
First submitted
12 Jul 2025
Start date
1 Jan 2025
Primary completion date
10 Jul 2025
Lead sponsor
Sohag University
NCT number
NCT07076732

What you commit to

  • Study type: Observational
  • Participants enrolled: 80
  • From 1 Jan 2025 to the primary completion date, 10 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of MI or coronary revascularization (PCI or bypass surgery) with acute/chronic infection.

Other illness

  • Autoimmune diseases.
  • Systemic inflammatory disease.
  • Patients with malignancy.
  • Chronic kidney disease.
  • Severe liver disease.

Lab values

  • Patients on treatment therapy which critically affects inflammatory cell count.

Other

  • Severe anemia.
  • Fever (\>38°C).

Who the study is looking for

  • Age ≥18 years old.
  • Both sexes.
  • Patients with acute myocardial infarction (AMI). Myocardial infarction with nonobstructive coronary arteries (MINOCA) is diagnosed if a patient fulfilled the AMI criteria in the absence of obstructive coronary arteries (type I: \<50% stenosis; or type II: no stenosis) as recommended by the recent American Heart Association statement that introduces an updated definition incorporating the 4th universal MI definition, which by agreement excludes Takotsubo syndrome and myocarditis from the eventual diagnosis of MINOCA.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sohag University
Coordinator of this site? Confirm its status
SohagEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.